6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
Choi RK, Chae IH, Oh JH, Jang WJ, Park YH, Chun WJ, Kim SH, Cho JH, Suh IW, Park JS, Choi JW, Kim BO, Doh JH, Kim DI, Hahn JY, Kim J, Choi KH, Park TK, Lee JM, Yang JH, Choi JH, Choi SH, Song YB, Oh JH, Cho DK, Lee JB, Doh JH, Kim SH, Jeong JO, Kang SH, Lee WS, Park HK, Jeong JO, Ahn KJ, Hwang JY, Hur SH, Rha SW, Cho DK, Jeong MH, Bae JH, Kim BO, Cho JH, Suh IW, Kim DI, Park HK, Park JS, Choi WG, Lee WS, Gwon HC, Gwon HC, Hahn JY, Song YB, Park TK, Yang JH, Choi JH, Choi SH, Choi SH, Choi WG, Bae JH, Park HS, Cho SC, Kang WY, Lim SH, Lee JB, Cha KS, Lee JM, 김무현
Lancet, 2018